Morgan Stanley’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3M | Buy |
7,025,463
+24,664
| +0.4% | +$53.8K | ﹤0.01% | 3063 |
|
|
2025
Q1 | $19.1M | Buy |
7,000,799
+2,592,546
| +59% | +$7.08M | ﹤0.01% | 2738 |
|
|
2024
Q4 | $18.3M | Sell |
4,408,253
-408,879
| -8% | -$1.7M | ﹤0.01% | 2837 |
|
|
2024
Q3 | $18.7M | Buy |
4,817,132
+177,970
| +4% | +$692K | ﹤0.01% | 2864 |
|
|
2024
Q2 | $18.2M | Buy |
4,639,162
+1,120,046
| +32% | +$4.39M | ﹤0.01% | 2769 |
|
|
2024
Q1 | $14.7M | Sell |
3,519,116
-3,442,904
| -49% | -$14.4M | ﹤0.01% | 3003 |
|
|
2023
Q4 | $32.7M | Buy |
6,962,020
+5,636,850
| +425% | +$26.5M | ﹤0.01% | 2883 |
|
|
2023
Q3 | $4.13M | Sell |
1,325,170
-296,847
| -18% | -$926K | ﹤0.01% | 3890 |
|
|
2023
Q2 | $7.45M | Sell |
1,622,017
-58,852
| -4% | -$270K | ﹤0.01% | 3449 |
|
|
2023
Q1 | $8.32M | Buy |
1,680,869
+120,348
| +8% | +$596K | ﹤0.01% | 3315 |
|
|
2022
Q4 | $8.52M | Buy |
1,560,521
+71,280
| +5% | +$389K | ﹤0.01% | 3233 |
|
|
2022
Q3 | $9.68M | Sell |
1,489,241
-65,599
| -4% | -$426K | ﹤0.01% | 3020 |
|
|
2022
Q2 | $7.35M | Buy |
1,554,840
+252,863
| +19% | +$1.2M | ﹤0.01% | 3397 |
|
|
2022
Q1 | $9.1M | Sell |
1,301,977
-74,248
| -5% | -$519K | ﹤0.01% | 3010 |
|
|
2021
Q4 | $14M | Buy |
1,376,225
+82,026
| +6% | +$836K | ﹤0.01% | 2545 |
|
|
2021
Q3 | $15.8M | Buy |
+1,294,199
| New | +$15.8M | ﹤0.01% | 2344 |
|